Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

Saúl Reyes, Anthony L. Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, Laura Airas, Reem F. Bunyan, Anneke van der Walt, Jiwon Oh, Joela Mathews, Farrah J. Mateen, Gavin Giovannoni

Research output: Contribution to journalReview ArticleResearchpeer-review

37 Citations (Scopus)


In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.

Original languageEnglish
Article number577627
Number of pages13
JournalJournal of Neuroimmunology
Publication statusPublished - 15 Aug 2021


  • COVID-19
  • Disease-modifying treatment
  • Multiple sclerosis
  • Pharmacovigilance
  • Telemedicine

Cite this